Clinical Trial Update: Trial for Treatment of Adult Patients With Standard Risk Acute Lymphoblastic Leukemia With Chemotherapy and Rituximab [Phase 4]

View source ↗

Summary

This clinical trial update reports completion of a Phase 4 study evaluating chemotherapy with rituximab in adult patients with standard-risk acute lymphoblastic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia

Drugs mentioned

• Rituximab (Rituxan) (rituximab)

Snippet

Sponsor: Johann Wolfgang Goethe University Hospital | Conditions: Adult Acute Lymphocytic Leukemia | Phase 4 | Status: COMPLETED